Statistics

Total Visits

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor49

Select a period of time:

Number of views in the range

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor33

Views

Views
February 20252
March 202515
April 20253
May 20251
June 20250
July 202511
August 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States6
Brazil3
Mexico2
Argentina1
Bolivia1
Germany1
Spain1
United Kingdom1
Hong Kong1
 

Top cities views

Views
Bluffton1
Hong Kong1
Hope1
Izmir1
Nova Resende1
Ourilândia do Norte Municipality1
Philadelphia1
Piracicaba1
Poza Rica1
Reynosa1